The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 19, 2013
Filed:
Jun. 15, 2010
Edward R. Bacon, Audubon, PA (US);
Thomas R. Bailey, Phoenixville, PA (US);
Nadine C. Becknell, Coatesville, PA (US);
Sankar Chatterjee, Wynnewood, PA (US);
Derek Dunn, Coatesville, PA (US);
Greg A. Hostetler, Newark, DE (US);
Robert L. Hudkins, Chester Springs, PA (US);
Kurt A. Josef, Radnor, PA (US);
Lars J. S. Knutsen, West Chester, PA (US);
Ming Tao, Maple Glen, PA (US);
Allison L. Zulli, Wayne, PA (US);
Edward R. Bacon, Audubon, PA (US);
Thomas R. Bailey, Phoenixville, PA (US);
Nadine C. Becknell, Coatesville, PA (US);
Sankar Chatterjee, Wynnewood, PA (US);
Derek Dunn, Coatesville, PA (US);
Greg A. Hostetler, Newark, DE (US);
Robert L. Hudkins, Chester Springs, PA (US);
Kurt A. Josef, Radnor, PA (US);
Lars J. S. Knutsen, West Chester, PA (US);
Ming Tao, Maple Glen, PA (US);
Allison L. Zulli, Wayne, PA (US);
Cephalon, Inc., Frazer, PA (US);
Abstract
The present invention is directed to novel pyridazinone derivatives that mediate enzymatic activity. In particular, the compounds and/or their pharmaceutically acceptable salts may be effective in the treatment of diseases or disease states related to the activity of the histamine Hreceptor, including, for example, neurodegenerative disorders, sleep/wake disorders, attention deficit hyperactivity disorder and cognition/cognitive disorders.